Exercise in neuromuscular disease

Muscle and Nerve

Volumn 48, Issue 1, 2013, Pages 3-20

  Anziska, Yaacov ^a   Sternberg, Alex ^a  

^a SUNY Downstate Medical Center   (United States)

Author keywords

Aerobic exercise; Deconditioning; Muscular dystrophy; Neuromuscular diseases; Neuromuscular electrical stimulation; Strength training

Indexed keywords

ACTIN; MYOSIN;

ADAPTATION; AEROBIC EXERCISE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BACKACHE; BEHAVIOR THERAPY; CARDIOPULMONARY FUNCTION; DERMATOMYOSITIS; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; ENDURANCE TRAINING; ERGOMETRY; EXERCISE; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FATIGUE; HEART OUTPUT; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; INCLUSION BODY MYOSITIS; KENNEDY DISEASE; LEAN BODY WEIGHT; LEG PAIN; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCLE ATROPHY; MUSCLE CONTRACTION; MUSCLE CONTRACTURE; MUSCLE HYPERTROPHY; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; MYOTONIC DYSTROPHY; NEUROMUSCULAR DISEASE; NEUROMUSCULAR ELECTRICAL STIMULATION; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PERIPHERAL CIRCULATION; POLIOMYELITIS; POLYMYOSITIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANCE TRAINING; SHOULDER PAIN; SPINAL BULBAR MUSCULAR ATROPHY; SPINAL MUSCULAR ATROPHY; WEIGHT BEARING;

ANIMALS; CLINICAL TRIALS AS TOPIC; EXERCISE; EXERCISE THERAPY; HUMANS; MUSCLE STRENGTH; NEUROMUSCULAR DISEASES; PHYSICAL ENDURANCE; RESISTANCE TRAINING;

EID: 84879551243     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23771     Document Type: Article

References (216)

1. Cup EH, Pieterse AJ, ten Broek-Pastoor JM, Munneke M, van Engelen BG, Hendricks HT, et al. Exercise therapy and other types of physical therapy for patients with neuromuscular disease: a systematic review. Arch Phys Med Rehabil 2007;88:1452-1464.
2. Eagle M. Report on the Muscular Dystrophy Campaign workshop: exercise in neuromuscular diseases. Newcastle, January 2002. Neuromuscul Disord 2002;12:975-983.
3. Fowler WM. Consensus conference summary: role of physical activity and exercise training in neuromuscular diseases. Am J Phys Med Rehabil 2002;81(Suppl):S187-S195.
4. Markert CD, Case LE, Carter GT, Furlong PA, Grange RW. Exercise and DMD Roundtable. Exercise and Duchenne muscular dystrophy: where we have been and where we need to go. Muscle Nerve 2012;45:746-751.
5. Timmons JA, Knudsen S, Rankinen T, Koch LG, Sarzynski M, Jensen T, et al. Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans. J Appl Physiol 2010;108:1487-1496.
6. Favier FB, Benoit H, Freyssenet D. Cellular and molecular events controlling skeletal muscle mass in response to altered use. Pflugers Arch 2008;456:587-600.
7. Grutel M. The sarcomere and the nucleus: functional links to hypertrophy, atrophy, and sarcopenia. Adv Exp Med Biol 2008;642:176-191.
8. Coble NO, Maloney FP. Interdisciplinary rehabilitation of multiple sclerosis and neuromuscular disorders. In: Maloney FP, Burks JS, Ringel SP, editors. Effects of exercise in neuromuscular disease. New York: JB Lippincott; 1985. p 228-238.
9. Wagner M, Vignos PJ, Fonow D. Serial isokinetic evaluations used for a patient with scapulperoneal muscular dystrophy: a case report. Phys Ther 1986;66:1110-1113.
10. Van Pomeren M, Selles RW, van Ginneken BT, Schreuders TA, Janssen WG, Stam HJ. The hypothesis of overwork weakness in Charcot-Marie-Tooth: a critical evaluation. J Rehabil Med 2009;41:32-34.
11. Vinci P, Esposito C, Perelli SL, Antenor JA, Thomas FP. Overwork weakness in Charcot-Marie-Tooth disease. Arch Phys Med Rehabil 2003;84:825-827.
12. Bennett RL, Knowlton GC. Overwork weakness in partially denervated skeletal muscle. Clin Orthop Relat Res 1958;12:22-29.
13. Kilmer DD. Response to resistive strengthening exercise training in humans with neuromuscular disease. Am J Phys Med Rehabil 2002;81(Suppl):S121-S126.
14. Abresch RT, Han JJ, Carter GT. Rehabilitation management of neuromuscular disease: the role of exercise training. J Clin Neuromuscul Dis 2009;11:7-21.
15. McDonald CM, Abresch RT, Carter GT. Profiles of neuromuscular diseases. Duchenne muscular dystrophy. Am J Phys Med Rehabil 1995;74(Suppl):S70-S92.
16. McDonald CM, Widman LM, Walsh DD, Walsh SA, Abresch RT. Use of step activity monitoring for continuous physical activity assessment in boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil 2005;86:802-808.
17. McDonald CM. Physical activity, health impairments, and disability in neuromuscular disease. Am J Phys Med Rehabil 2002;81(Suppl):S108-S120.
18. McCrory MA, Kim HR, Wright NC. Energy expenditure, physical activity, and body composition of ambulatory adults with hereditary neuromuscular disease. Am J Clin Nutr 1998;67:1162-1169.
19. Phillips M, Flemming N, Tsintzas K. An exploratory study of physical activity and perceived barriers to exercise in ambulant people with neuromuscular disease compared with unaffected controls. Clin Rehabil 2009;23:746-755.
20. Engel JM, Kartin D, Carter GT, Jensen MP, Jaffe KM. Pain in youths with neuromuscular disease. Am J Hosp Palliat Care 2009;26:405-412.
21. Suokas KI, Haanpaa M, Kautiainen H, Udd B, Hietaharju AJ. Pain in patients with myotonic dystrophy type 2: a postal survey in Finland. Muscle Nerve 2012;45:70-74.
22. George A, Schneider-Gold C, Zier S, Reiners K, Sommer C. Musculoskeletal pain in patients with myotonic dystrophy type 2. Arch Neurol 2004;61:1938-1942.
23. Tieleman AA, Jenks KM, Kalkman JS, Borm G, van Englen BG. High disease impact of myotonic dystrophy type 2 on physical and mental functioning. J Neurol 2011;258:1820-1826.
24. Jensen MP, Abresch RT, Carter GT, McDonald CM. Chronic pain in persons with neuromuscular disease. Arch Phys Med Rehabil 2005;86:1155-1163.
25. Miller RG. Role of fatigue in limiting physical activities in humans with neuromuscular diseases. Am J Phys Med Rehabil 2002;81(Suppl):S99-S107.
26. Lou JS, Weiss MD, Carter GC. Assessment and management of fatigue in neuromuscular disease. Am J Hosp Palliat Care 2010;27:145-157.
27. Hoberman M. Physical medicine and rehabilitation: its value and limitations in progressive muscular dystrophy. Phys Ther Rev 1955;38:26-32.
28. Fowler WM, Pearson CM, Egstrom GH, Gardner GW. Ineffective treatment of muscular dystrophy with an anabolic steroid and other measures. N Engl J Med 1965;272:875-882.
29. McCartney N, Moroz D, Garner SH, McComas AJ. The effects of strength training in patients with selected neuromuscular diseases. Med Sci Sports Exerc 1988;20:362-368.
30. Aitkens SG, McCrory MA, Kilmer DD, Bernauer EM. Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 1993;74:711-715.
31. Kilmer DD, McCrory MA, Wright NC, Aitkens SG, Bernauer EM. The effect of a high resistance exercise program in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 1994;75:560-563.
32. Florence JM, Hagberg JM. Effect of training on the exercise responses of neuromuscular disease patients. Med Sci Sports Exerc 1984;16:460-465.
33. Taivassalo T, De Stefano N, Chen J. Karpati G, Arnold DL, Argov Z. Short-term aerobic training response in chronic myopthies. Muscle Nerve 1999;22:1239-1243.
34. Wright NC, Kilmer DD, McCrory MA, Aitkens SG, Holcomb BJ, Bernauer EM. Aerobic walking in slowly progressive neuromuscular disease: effect of a 12-week program. Arch Phys Med Rehabil 1996;77:64-69.
35. Dal Bello-Haas V, Florence JM, Krivickas LS. Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Syst Rev 2008;2:CD005229.
36. Strickland D, Smith SA, Dolliff G, Goldman L, Roelofs RI. Physical activity, trauma, and ALS: a case-control study. Acta Neurol Scand 1996;94:45-50.
37. Deforges S, Branchu J, Biondi O, Grondard C, Pariset C, Lecolle S, et al. Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. J Physiol 2009;587:3561-3572.
38. Liebetanz D, Hagemann K, von Lewinski F, Kahler E, Paulus W. Extensive exercise is not harmful in amyotophic lateral sclerosis. Eur J Neurosci 2004;20:3115-3120.
39. Pinto AC, Alves M, Nogueira A, Evangelista T, Carvalho J, Coehlo A, et al. Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise? J Neurol Sci 1999;169:69-75.
40. Drory VE, Goltsman E, Reznik JG, Mosek A, Korczyn AD. The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci 2001;191:133-137.
41. Aksu S, Karaduman A, Yakut Y, Tan E. The effects of exercise therapy in amyotrophic lateral sclerosis patients. Fitz Rehab 2002;13:105-112.
42. Dal Bello-Haas V, Florence JM, Kloos AD, Scheirbecker J, Lopate G, Hayes SM, et al. A randomized controlled trial of resistance exercise in individuals with ALS. Neurology 2007;68:2003-2007.
43. Van Groenestijn AC, van de Port IG, Schroder CD, Post MW, Grupstra HF, Kruitwagen ET, et al. Effects of aerobic exercise therapy and cognitive behavioral therapy on functioning and quality of life in amyotrophic lateral sclerosis: protocol of the FACTS-2-ALS trial. BMC Neurol 2011;11:70-81.
44. Pinto S, Swash M, de Carvalho M. Respiratory exercise in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2012;13:33-43.
45. Cheah BC, Borland RA, Brodaty NE, Zoing MC, Jeffrey SE, McKenzie DK, et al. INSPIRATionAL-INSPIRAtory muscle training in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009;10:384-392.
46. Fischbeck KH, Souders D, La Spada A. A candidate gene for X-linked spinal muscular atrophy. Adv Neurol 1991;56:209-213.
47. Presiler N, Andersen G, Thogersen F, Crone C, Jeppesen TD, Wibrand F, et al. Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy Disease). Neurology 2009;72:317-323.
48. Markowitz JA, Singh P, Darras BT. Spinal muscular atrophy: a clinical and research update. Pediatr Neurol 2012;46:1-12.
49. Grondard C, Biondi O, Armand AS, Lecolle S, Della Gaspera B, Pariset C, et al. Regular exercise prolongs survival in a type 2 spinal muscular atrophy model mouse. J Neurosci 2005;25:7615-7612.
50. Biondi O, Grondard C, Lecolle S, Deforges S, Pariset C, Lopes P, et al. Exercise-induced activation of NMDA receptor promotes motor unit development and survival in a type 2 spinal muscular atrophy model mouse. J Neurosci 2008;28:953-962.
51. Charbonnier F. Exercise-induced neuroprotection in SMA model mice: a means for determining new therapeutic strategies. Mol Neurobiol 2007;35:217-223.
52. Cunha MC, Oliveira AS, Labronici RH, Gabbai AA. Spinal muscular atrophy II (intermediary) and III (Kugelberg-Welander). Evolution of 50 patients with physiotherapy and hydrotherapy in a swimming pool. Arq Neuropsiquiatr 1996;54:402-406.
53. Salem Y, Gropack SJ. Aquatic therapy for a child with type III spinal muscular atrophy: a case report. Phys Occup Ther Pediatr 2010;30:313-324.
54. Jones DR, Speier J, Canine K, Owen R, Stull GA. Cardiorespiratory responses to aerobic training by patients with postpoliomyelitis sequelae. JAMA 1989;261:3255-3258.
55. Nollet F, Beelen A, Prins MH, de Visser M, Sargeant AJ, Lankhorst GJ, et al. Disability and functional assessment in former polio patients with and without postpolio syndrome. Arch Phys Med Rehabil 1999;80:136-143.
56. Nollet F, Beelen A, Sargeant AJ, de Visser M, Lankhorst GJ, de Jong BA. Submaximal exercise capacity and maximal power output in polio subjects. Arch Phys Med Rehabil 2001;82:1678-1685.
57. Kriz JL, Jones DR, Speier JL, Canine JK, Owen RR, Serfass RC. Cardiorespiratory responses to upper extremity aerobic training by postpolio subjects. Arch Phys Med Rehabil 1992;73:49-54.
58. Dean E, Ross J. Effect of modified aerobic training on movement energetics in polio survivors. Orthopedics 1991;14:1243-1246.
59. Einarsson G. Muscle conditioning in late poliomyelitis. Arch Phys Med Rehabil 1991;72:11-14.
60. Agre JC, Rodriguez AA, Franke TM. Strength, endurance, and work capacity after muscle strengthening exercise in postpolio subjects. Arch Phys Med Rehabil 1997;78:681-686.
61. Spector SA, Gordon PL, Feuerstein IM, Sivakumar K, Hurley BF, Dalakas MC. Strength gains without muscle injury after strength training in patients with postpolio muscular atrophy. Muscle Nerve 1996;19:1282-1290.
62. Ernstoff B, Wetterqvist H, Kvist H, Grimby G. Endurance training effect on individuals with postpoliomyelitis. Arch Phys Med Rehabil 1996;77:843-848.
63. Willen C, Sunnerhagen KS, Grimby G. Dynamic water exercise in individuals with late poliomyelitis. Arch Phys Med Rehabil 2001;82:66-72.
64. Menotti F, Felici F, Damiani A, Mangiola F, Vannicelli R, Macaluso A. Charcot-Marie-Tooth 1A patients with low level of impairment have a higher energy cost of walking than healthy individuals. Neuromuscul Disord 2011;21:52-57.
65. Ramdharry GM, Day BL, Reilly MM, Marsden JF. Hip flexor fatigue limits walking in Charcot-Marie-Tooth disease. Muscle Nerve 2009;40:103-111.
66. Vinci P. Strengthening of the proximal muscles in Charcot-Marie-Tooth. Arch Phys Med Rehabil 2001;82:563.
67. Lindeman E, Leffers P, Spaans F, Drukker J, Reulen J, Kerckhoffs M, et al. Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial. Arch Phys Med Rehabil 1995;76:612-620.
68. Burns J, Raymond J, Ouvrier R. Feasibility of foot and ankle strength training in childhood Charcot-Marie-Tooth disease. Neuromuscul Disord 2009;19:818-821.
69. Chetlin RD, Gutmann L, Tarnopolsky M, Ullrich IH, Yeater RA. Resistance training effectiveness in patients with Charcot-Marie-Tooth disease: recommendations for exercise prescription. Arch Phys Med Rehabil 2004;85:1217-1223.
70. Smith CA, Chetlin RD, Gutmann L, Yeater RA, Always SE. Effect of exercise and creatine on myosin heavy chain isoform composition in patients with Charcot-Marie-Tooth disease. Muscle Nerve 2006;34:586-594.
71. Chetlin RD, Gutmann L, Tarnopolsky MA, Ullrich IH, Yeater RA. Resistance training exercise and creatine in patients with Charcot-Marie-Tooth disease. Muscle Nerve 2004;30:69-76.
72. Maggi G, Monti Bragadin M, Padua L, Fiorina E, Bellone E, Grandis M, et al. Outcome measures and rehabilitation treatment in patients affected by Charcot-Marie-Tooth neuropathy: a pilot study. Am J Phys Med Rehabil 2011;90:628-636.
73. El Mhandi L, Pichot V, Calmels P, Gautheron V, Roche F, Feasson L. Exercise training improves autonomic profiles in patients with Charcot-Marie-Tooth disease. Muscle Nerve 2011;44:732-736.
74. El Mhandi L, Millet GY, Calmels P, Richard A, Oullion R, Gautheron V, et al. Benefits of interval training on fatigue and functional capacities in Charcot-Marie-Tooth disease. Muscle Nerve 2008;37:601-610.
75. Lohi EL, Lindberg C, Andersen O. Physical training effects in myasthenia gravis. Arch Phys Med Rehabil 1993;74:1178-1180.
76. Stout JR, Eckerson JM, May E, Coulter C, Bradley-Popovich GE. Effects of resistance exercise and creatine supplementation on myasthenia gravis: a case study. Med Sci Sports Exerc 2001;33:869-872.
77. Grohar-Murray ME, Becker A, Reilly S, Ricci M. Self-care actions to manage fatigue among myasthenia gravis patients. J Neurosci Nurs 1998;30:191-199.
78. Lucia A, Mate-Munoz JL, Perez M, Foster C, Gutierrez-Rivas E, Arenas J. Double trouble (McArdle's disease and myasthenia gravis): how can exercise help? Muscle Nerve 2007;35:125-128.
79. Fregonezi G, Resqueti VR, Guell R, Pradas J, Casan P. Effects of 8-week interval-based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest 2005;128:1524-1530.
80. Weiner P, Gross D, Meiner Z, Ganem R, Weiner M, Zamir D, et al. Respiratory muscle training in patients with moderate-severe myasthenia gravis. Can J Neurol Sci 1998;25:236-241.
81. Rassler B, Hallebach G, Kalischewski P, Baumann I, Schauer J, Spengler CM. The effect of respiratory muscle endurance training in patients with myasthenia gravis. Neuromuscul Disord 2007;17:385-391.
82. Markert CD, Ambrosio F, Call JA, Grange RW. Exercise and Duchenne muscular dystrophy: toward evidence-based exercise prescription. Muscle Nerve 2011;43:464-478.
83. Kobayashi YM, Rader EP, Crawford RW, Iyengar NK, Thedens DR, Faulkner JA, et al. Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature 2008;456:511-515.
84. Clarke MS, Khakee R, McNeil PL. Loss of cytoplasmic basic fibroblast growth factor from physiologically wounded myofibers of normal and dystrophic muscle. J Cell Sci 1993;106:121-133.
85. Yeung EW, Whitehead NP, Suchyna TM, Gottlieb PA, Sachs F, Allen DG. Effects of stretch-activated channel blockers on [Ca2+] and muscle damage in the mdx mouse. J Physiol 2005;562:367-380.
86. Constantin B, Sebille S, Cognard C. New insights into the regulation of calcium transfers by muscle dystrophin-based cytoskeleton: implications in DMD. J Muscle Res Cell Motil 2006;27:375-386.
87. Fraysse B, Liantonio A, Cetrone M, Burdi R, Pierno S, Frigeri A, et al. The alteration of calcium homeostasis in adult dystrophic mdx muscle fibers is worsened by a chronic exercise in vivo. Neurobiol Dis 2004;17:144-154.
88. Shkryl VM, Martins AS, Ullrich ND, Nowycky MC, Niggli E, Shirokova N. Reciprocal amplification of ROS and Ca(2+) signals in stressed mdx dystrophic skeletal muscle fibers. Pflugers Arch 2009;458:915-928.
89. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev 2003;83:731-801.
90. Webster C, Blau HM. Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: implications for cell and gene therapy. Somat Cell Mol Genet 1990:16:557-565.
91. Berg Z, Beffa LR, Cook DP, Cornelison DD. Muscle satellite cells from GRMD dystrophic dogs are not phenotypically distinguishable from wild type satellite cells in ex vivo culture. Neuromuscul Disord 2011;21:282-290.
92. Kadi F, Charifi N, Denis C, Lexell J, Andersen JL, Schjerling P, et al. The behavior of satellite cells in response to exercise: what have we learned from human studies? Pflugers Arch 2005;451:319-327.
93. Ambrosio F, Kadi F, Lexell J, Fitzgerald GK, Boninger ML, Huard J. The effect of muscle loading on skeletal muscle regenerative potential: an update of current research findings relating to aging and neuromuscular pathology. Am J Phys Med Rehabil 2009;88:144-155.
94. Hayes A, Williams DA. Beneficial effects of voluntary wheel-running on the properties of dystrophic mouse muscle. J Appl Physiol 1996;80:670-679.
95. Wineinger MA, Abresch RT, Walsh SA, Carter GT. Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice. Am J Phys Med Rehabil 1998;77:20-27.
96. Carter GT, Abresch RT, Fowler WM Jr. Adaptations to exercise training and contraction-induced muscle injury in animal models of muscular dystrophy. Am J Phys Med Rehabil 2002;81(Suppl):S151-S161.
97. Hayes A, Williams DA. Contractile function and low-intensity exercise effects of old dystrophic (mdx) mice. Am J Physiol 1998;274:C1138-C1144.
98. Carter GT, Kikuchi N, Abresch RT, Walsh SA, Horasek SJ. Effects of exhaustive concentric and eccentric exercise on murine skeletal muscle. Arch Phys Med Rehabil 1994;75:555-559.
99. Vignos PJ Jr, Watkins MP. The effect of exercise in muscular dystrophy. JAMA 1966;197:843-848.
100. Scott OM, Hyde SA, Goddard C, Jones R, Dubowitz V. Effect of exercise in Duchenne muscular dystrophy. Physiotherapy 1981;67:174-176.
101. De Lateur BJ, Giaconi RM. Effect on maximal strength of submaximal exercise in Duchenne muscular dystrophy. Am J Phys Med 1979;58:26-36.
102. Topin N, Matecki S, Le Bris S, Rivier F, Echenne B, Prefaut C, et al. Dose-dependent effect of individualized respiratory muscle raining in children with Duchenne muscular dystrophy. Neuromuscul Disord 2002;12:576-583.
103. Sveen ML, Jeppesen TD, Hauerslev S, Kober L, Krag TO, Vissing J. Endurance training improves fitness and strength in patients with Becker muscular dystrophy. Brain 2008;131:2824-2831.
104. Jansen M, de Groot IJ, van Alfen N, Geurts AC. Physical training in boys with Duchenne muscular dystrophy: the protocol of the No Use is Disuse study. BMC Pediatr 2010;10:55-70.
105. Lindeman E, Leffers P, Spaans F, Drukker J, Reulen J, Kerckhoffs M, et al. Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial. Arch Phys Med Rehabil 1995;76:612-620.
106. Lindeman E, Spaans F, Reulen J, Leffers P, Drukker J. Progressive resistance in neuromuscular patients. Effects on force and surface EMG. J Electromyogr Kinesiol 1999;9:379-384.
107. Tollback A, Erikssson S, Wredenberg A, Jenner G, Vargas R, Borg K, Ansved T. Effects of high resistance training in patients with myotonic dystrophy. Scand J Rehabil Med 1999;31:9-16.
108. Orngreen MC, Olsen DB, Vissing J. Aerobic training in patients with myotonic dystrophy type 1. Ann Neurol 2005;57:754-757.
109. Trenell MI, Thompson CH, Sue CM. Exercise and myotonic dystrophy. A 31P magnetic resonance spectroscopy and magnetic resonance imaging case study. Ann Neurol 2006;59:871-872.
110. Kierkegaard M, Harms-Ringdahl K, Edstrom L, Widen Holmqvist L, Tollback A. Feasibility and effects of a physical exercise programme in adults with myotonic dystrophy type 1: a randomized controlled pilot study. J Rehabil Med 2011;43:695-702.
111. Missaoui B, Rakotovao E, Bendaya S, Mane M, Pichon B, Faucher M, et al. Posture and gait abilities in patients with myotonic dystrophy. Evaluation on the short-term of a rehabilitation program. Ann Phys Rehabil Med 2010;53:387-398.
112. Aldehag AS, Jonsson H, Ansved T. Effects of a hand training programme in five patients with myotonic dystrophy type 1. Occup Ther Int 2005;12:14-27.
113. Sveen ML, Jeppesen TD, Hauerslev S, Krag TO, Vissing J. Endurance training: an effective and safe treatment for patients with LGMD2I. Neurology 2007;68:59-61.
114. Colson S, Benchortane M, Tanant V, Faghan J, Fournier-Mehouas M, Benaim C, et al. Neuromuscular electrical stimulation training: a safe and effective treatment in facioscapulohumeral muscular dystrophy patients. Arch Phys Med Rehabil 2010;91:697-702.
115. Van der Kooi EL, Vogels OJM, van Asseldonk RJ, Lindeman E, Hendriks JC, Wohgemuth M, et al. Strength training and albuterol in facioscapulohumeral muscular dystrophy. Neurology 2004;63:702-708.
116. Van der Kooi EL, Kalkman JS, Lindeman E, Hendriks JC, van Engelen BG, Bleijenberg G, et al. Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy. J Neurol 2007;254:931-940.
117. Olsen DB, Orngreen MC, Vissing J. Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy. Neurology 2005;64:1064-1066.
118. Wiesinger GF, Quittan M, Nuhr M, Volc-Platzer B, Ebenbichler G, Zehetgruber M, et al. Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls. Arch Phys Med Rehabil 2000;81:1-5.
119. Henriksson KG, Lindvall B. Polymyositis and dermatomyositis 1990: diagnosis, treatment and prognosis. Prog Neurobiol 1990;35:181-193.
120. Chung YL, Mitchell HL, Houssien DA, Al-Mahrouki H, Carr AJ, Scott DL. A comparative study of outcome in myositis and other musculoskeletal disorders assessed using Nottingham Health Profile. Clin Exp Rheumatol 2001;19:447-450.
121. Sultan SM, Ioannou Y, Moss K, Isenberg DA. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology 2002;41:22-26.
122. Clarke AE, Bloch DA, Medsger TA Jr, Oddis CV. A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis. Arthritis Rheum 1995;38:1218-1224.
123. Hollister JR. The untoward effects of steroid treatment on the musculoskeletal system and what to do about them. J Asthma 1992;29:363-368.
124. Cea G, Bendahan D, Manners D, Hilton-Jones D, Lodi R, Stykes P, et al. Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: a quantitative 31P-magnetic resonance spectroscopy and MRI study. Brain 2002;125:1635-1645.
125. Nyberg P, Wikman AL, Nennesmo I, Lundberg I. Increased expression of interleukin 1 alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis. J Rheumatol 2000;27:940-948.
126. Englund P, Nennesmo I, Klareskog L, Lundberg IE. Interleukin-1 alpha expression in capillaries and major histocompatability complex class I expression in type II muscle fibers from polymyositis and dermatomyositis: important pathogenic features independent of inflammatory cell clusters in muscle tissue. Arthritis Rheum 2002;46:1044-1055.
127. Park JH, Olsen NJ, King L Jr, Vital T, Buse R, Kari S, et al. Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in he amyopathic and myopathic variants of dermatomyositis. Arthritis Rheum 1995;38:68-77.
128. Pfleiderer B, Lange J, Loske KD, Sunderkotter C. Metabolic disturbances during short exercises in dermatomyositis revealed by real-time functional 31P magnetic resonance spectroscopy. Rheumatology (Oxford) 2004;43:696-703.
129. Lawson MM. The benefits and limitations of a physical training program in patients with inflammatory myositis. Curr Rheum Rep 2001;3:317-324.
130. Alexanderson H, Lundberg IE. The role of exercise in the rehabilitation of idiopathic inflammatory myopathies. Curr Opin Rheumatol 2005;17:164-171.
131. Escalante A, Miller L, Beardmore TD. Resistive exercise in the rehabilitation of polymyositis/dermatomyositis. J Rheumatol 1993;20:1340-1344.
132. Wiesinger GF, Quittan M, Aringer M, Seeber A, Volc-Platzer B, Smolen J, et al. Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme. Br J Rheumatol 1998;37:196-200.
133. Nader GA, Dastmalchi M, Alexanderson H, Grundtman C, Gernapudi R, Esbjornsson M, et al. A longitudinal, integrated, clinical, histological and mRNA profiling study of resistance exercise in myositis. Mol Med 2010;16:455-464.
134. Arnardottir S, Alexanderson H, Lundberg IE, Borg K. Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology, and inflammatory reaction. J Rehabil Med 2003;35:31-35.
135. Dastmalchi M, Alexanderson H, Loell I, Stahlberg M, Borg K, Lundberg IE, et al. Effect of physical training on the proportion of slow-twitch type I muscle fibers, a novel nonimmune-mediated mechanism for muscle impairment in polymyositis or dermatomyositis. Arthritis Rheum 2007;57:1303-1310.
136. Alexanderson H. Exercise effects in patients with adult idiopathic inflammatory myopathies. Curr Opin Rheumatol 2009;21:158-163.
137. Wiesinger GF, Quittan M, Graninger M, Seeber A, Ebenbichler G, Sturm B, et al. Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients. Br J Rheumatol 1998;37:1338-1342.
138. Alexanderson H, Dastmalchi M, Esbjornsson-Liljedahl M, Opava CH, Lundberg IE. Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis. Arthritis Rheum 2007;57:768-777.
139. Alexanderson H, Stenstrom CH, Lundberg I. Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study. Rheumatology (Oxford) 1999;38:608-611.
140. Johnson LG, Collier KE, Edwards DJ, Philippe DL, Eastwood PR, Waters SE, et al. Improvement in aerobic capacity after an exercise program in Sporadic Inclusion body myositis. J Clin Neuromuscul Dis 2009;10:178-184.
141. Spector SA, Lemmer JT, Koffman BM, Flesiher TA, Feuerstein IM, Hurley BF, et al. Safety and efficacy of strength training in patients with sporadic inclusion body myositis. Muscle Nerve 1997;20:1242-1248.
142. Berardo A, DiMauro S, Hirnao M. A diagnostic algorithm for metabolic myopathies. Curr Neurol Neurosci Rep 2010;10:118-126.
143. Taivassalo T, Hallar RG. Implications of exercising training in mtDNA defects-use it or lose it? Biochim Biophys Acta 2004;1659:221-231.
144. Haller RG, Lewis SF, Cook JD, Blomqvist CG. Myophosphorylase activity impairs muscle oxidative metabolism. Ann Neurol 1985;17:196-199.
145. Dandurand RJ, Matthews PM, Arnold DL, Eidelman DH. Mitochondrial disease: pulmonary function, exercise performance, and blood lactate levels. Chest 1995;108:182-189.
146. Lindholm H, Lofberg M, Somer H, Naveri H, Sovijarvi A. Abnormal blood lactate accumulation after exercise in patients with multiple mitochondrial DNA deletions and minor muscular symptoms. Clin Physiol Funct Imaging 2004;24:109-115.
147. Freyssenet D, Berthon P, Denis C. Mitochondrial biogenesis in skeletal muscle in response to endurance exercises. Acta Physiol Biochem 1996;104:129-141.
148. Little JP, Safdar A, Wilkin GP, Tarnopolsky MA, Gibala MJ. A practical model of low-volume high-intensity interval training induces mitochondrial biogenesis in human skeletal muscle: potential mechanisms. J Physiol 2010;588:1011-1022.
149. Adhihetty PJ, Irrcher I, Joseph AM, Ljubicic V, Hood DA. Plasticity of skeletal muscle mitochondria in response to contractile activity. Exp Physiol 2003;88:99-107.
150. Joseph AM, Pilegaard H, Litvintsev A, Leick L, Hood DA. Control of gene expression and mitochondrial biogenesis in the muscular adaptation to endurance exercise. Essays Biochem 2006;42:13-29.
151. Takahashi M, Chesley A, Freyssenet D, Hood DA. Contractile activity-induced adaptations in the mitochondrial protein import system. Am J Physiol 1998;274:1380-1387.
152. Taivassalo T, Shoubridge EA, Chen J, Eng M, Kennaway NG, DiMauro S, et al. Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects. Ann Neurol 2001;50:13-141.
153. Jeppesen TD, Schwartz M, Olsen DB, Wibrand F, Krag T, Duno M, et al. Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy. Brain 2006;12:3402-3412.
154. Taivassalo T, Gardner JL, Taylor RW, Schaefer AM, Newman J, Barron MJ, et al. Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. Brain 2006;129:3391-3401.
155. Taivassalo T, De Stefano N, Chen J, Karpati G, Arnold DL, Argov Z. Short-term aerobic training response in chronic myopthies. Muscle Nerve 1999;22:1239-1243.
156. Jeppesen TD, Duno M, Schwartz M, Krag T, Rafiq J, Wibrand F, et al. Short- and long-term effects of endurance training in patients with mitochondrial myopathy. Eur J Neurol 2009;16:1336-1339.
157. Walsh B, Tonkonogi M, Sahlin K. Effect of endurance training on oxidative and antioxidative function in human permeabilized muscle fibers. Pfugers Arch 2001;442:420-425.
158. Dudley GA, Tullson PC, Terjung RL. Influence of mitochondrial content on the sensitivity of respiratory control. J Biol Chem 1987;262:9109-9114.
159. Hood DA. Invited review: contractile activity-induced mitochondrial biogenesis in skeletal muscle. J Appl Physiol 2001;90:1137-1157.
160. Taivassalo T, Shoubridge E, Wyrick P, Lofberg M, Haller RG. Resistance exercise training for mitochondrial myopathies: effects on muscle strength and mitochondrial function. Med Sci Sports Exerc 2002;34:A943 (Abstract).
161. Cejudo P, Bautista J, Montemayor T, Villagomez R, Jimenez L, Ortega F, et al. Exercise training in mitochondrial myopathy: a randomized controlled trial. Muscle Nerve 2005;32:342-350.
162. Case LE, Kishnani PS. Physical therapy management of Pompe disease. Genet Med 2006;8:318-327.
163. Culper EJ, Berger KI, Leshner RT, Wolfe GI, Han JJ, Barohn RJ, et al. Consensus treatment recommendations for late-onset Pompe disease. Muscle Nerve 2012;45:319-333.
164. Case LE, Beckemeyer AA, Kishnani PS. Infantile Pompe disease on ERT-Update on clinical presentation, musculoskeletal management, and exercise considerations. Am J Med Genet 2012;160:69-79.
165. Hagemans ML, van Schie SP, Janssens AC, van Doorn PA, Reuser AJ, van der Ploeg AT. Fatigue: an important feature of late-onset Pompe disease. J Neurol 2007;254:941-945.
166. Slonim AE, Bulone L, Goldberg T, Minikes J, Slonim E, Galanko J, et al. Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve 2007;35:70-77.
167. Terzis G, Dimopoulos F, Papadimas GK, Papadopoulos C, Spengos K, Fatouros I, et al. Effect of aerobic and resistance training on late-onset Pompe disease patients receiving enzyme replacement therapy. Mol Genet Metab 2011;104:279-283.
168. Strothotte S, Strigl-Pill N, Grunert B, Kornblum C, Eger K, Wessig C, et al. Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. J Neurol 2010;257:91-97.
169. Jones HN, Moss T, Edwards L, Kishnani PS. Increased inspiratory and expiratory muscle strength following respiratory muscle strength training (RMST) in two patients with late-onset Pompe disease. Mol Genet Metab 2011;104:417-420.
170. Vissing J, Haller RG. The effect of oral sucrose on exercise tolerance in patients with McArdle's disease. N Engl J Med 2003;349:2503-2509.
171. Ollivier K, Hogrel JY, Gomez-Merino D, Romero NB, Laforet P, Eymard B, et al. Exercise tolerance and daily life in McArdle's disease. Muscle Nerve 2005;31:637-641.
172. Coakley JH, Wagenmakers AJ, Edwards RH. Relationship between ammonia, heart rate, and exertion in McArdle's disease. Am J Physiol 1992;262:E167-E172.
173. De Stefano N, Argov Z, Matthews PM, Karparti G, Arnold DL. Impairment of muscle mitochondrial oxidative metabolism in McArdle's disease. Muscle Nerve 1996;19:764-769.
174. Vissing J, Vissing SF, MacLean D, Saltin B, Quistorff B, Haller RJ. Sympathetic activation in exercise is not dependent on muscle acidosis. Direct evidence from studies in metabolic myopathies. J Clin Invest 1998;101:1654-1660.
175. Quinlivan R, Vissing J, Hilton-Jones D, Buckley J. Physical training for McArdle disease. Cochrane Database Syst Rev 2011;12:CD007931.
176. Haller RG, Wyrick P, Taivassalo T, Vissing J. Aerobic conditioning: an effective therapy in McArdle's disease. Ann Neurol 2006;59:922-928.
177. Mate-Munoz JL, Moran M, Perez M, Chamorro-Vina C, Gomez-Gallego F, Santiago C, et al. Favorable responses to acute and chronic exercise in McArdle patients. Clin J Sport Med 2007;17:297-303.
178. Ollivier K, Hogrel JY, Gomez-Merino D, Berkani M, Eymard B, Portero P. Effects of an endurance training on patients with McArdle disease. Science&Sports 2005;20:21-26.
179. Kilmer DD. The role of exercise in neuromuscular disease. Phys Med Rehabil Clin N Am 1998;9:115-125.
180. Sackley C, Disler PB, Turner-Stokes L, Wade DT, Brittle N, Hoppitt T. Rehabilitation interventions for foot drop in neuromuscular disease. Cochrane Database Syst Rev 2009;3:CD003908.
181. Salsabili H, Bahrpeyma F, Forogh B, Rajabali S. Dynamic stability training improves standing balance control in neuropathic patients with type 2 diabetes. J Rehabil Res Dev 2011;48:775-786.
182. Clemson L, Fiatarone SM, Bundy A, Cumming RG, Manollaras K, O'Loughlin P, et al. Integration of balance and strength training into daily life activity to reduce the rate of falls in older people (the LiFE study): randomized parallel trial. BMJ 2012;345:e4547.
183. Missaoui B, Rakotovao E, Bendaya S, Mane M, Pichon B, Faucher M, et al. Posture and gait abilities in patients with myotonic dystrophy (Steinert disease). Evaluation on the short-term of a rehabilitation program. Ann Phys Rehabil Med 2010;53:387-398.
184. Au-Yeung SS, Hui-Chan CW, Tang JC. Short-form Tai Chi improves standing balance of people with chronic stroke. Neurorehabil Neural Repair 2009;23:515-522.
185. Voukelatos A, Cumming RG, Lord SR, Rissel C. A randomized, controlled trial of tai chi in the prevention of falls: the Central Sydney tai chi trial. J Am Geriatr Soc 2007;55:1185-1191.
186. Lan C, Lai JS, Chen SY, Wong MK. Tai Chi Chuan to improve muscular strength and endurance in elderly individuals: a pilot study. Arch Phys Med Rehabil 2000;81:604-607.
187. Weerapong P, Hume PA, Kolt GS. The mechanisms of massage and effects on performance, muscle recovery, and injury prevention. Sports Med 2005;35:235-256.
188. Crane JD, Ogborn DI, Cupido C, Melov S, Hubbard A, Bourgeois JM, et al. Massage therapy attenuates inflammatory signaling after exercise-induced muscle damage. Sci Transl Med 2012;4:119ra13.
189. Blatzheim K. Interdisciplinary palliative care, including massage, in treatment of amyotrophic lateral sclerosis. J Bodyw Mov Ther 2009;13:328-335.
190. Dal Bello-Haas V, Kloos AD, Mitsumoto H. Physical therapy for a patient through six stages if amyotrophic lateral sclerosis. Phys Ther 1998;78:1312-1324.
191. Norrbrink C, Lundberg T. Acupuncture and massage therapy for neuropathic pain following spinal cord injury: an exploratory study. Acupunct Med 2011;29:108-115.
192. Cunningham JE, Kelechi T, Sterba K, Barthelemy N, Falkowski P, Chin SH. Case report of a patient with chemotherapy-induced peripheral neuropathy treated with manual therapy (massage). Support Care Cancer 2011;19:1473-1476.
193. Sanjak M, Bravver E, Bockenek WL, Norton HJ, Brooks BR. Supported treadmill ambulation for amyotrophic lateral sclerosis: a pilot study. Arch Phys Med Rehabil 2010;91:1920-1929.
194. Banala SK, Kim SH, Agarwal SK, Scholz JP. Robot assisted gait training with active leg exoskeleton. IEEE trans Neural Syst Rehabil Eng 2009;17:2-8.
195. Mehrholz J, Werner C, Kugler J, Pohl M. Electromechanical-assisted training for walking after stroke. Cochrane Database Syst Rev 2007;4:CD006185.
196. Mehrholz J, Hadrich A, Platz T, Kugler J, Pohl M. Electromechanical and robot-assisted arm training for improving generic activities of daily living, arm function, and arm muscle strength after stroke. Cochrane Database Syst Rev 2012;6:CD006876.
197. Gerovasili V, Stefanidis K, Vitzilaios K, Karatzanos E, Politis P, Koroneos A, et al. Electrical muscle stimulation preserves the muscle mass of critically ill patients: a randomized study. Crit Care 2009;13:R161.
198. Gibson JN, Smith K, Rennie MJ. Prevention of disuse muscle atrophy by means of electrical stimulation: maintenance of protein synthesis. Lancet 1988;2:767-770.
199. Maffiuletti NA. Physiological and methodological considerations for the use of neuromuscular electrical stimulation. Eur J Appl Physiol 2010;110:223-234.
200. Nosaka K, Aldayel A, Jubeau M, Chen TC. Muscle damage induced by electrical stimulation. Eur J Appl Physiol 2011;111:2427-2437.
201. Maffiuletti NA, Minetto MA, Farina D, Bottinelli R. Electrical stimulation for neuromuscular testing and training: state-of-the-art and unresolved issues. Eur J Appl Physiol 2011;111:2391-2397.
202. Theurel J, Lepers R, Pardon L, Maffiuletti NA. Differences in cardiorespiratory and neuromuscular responses between voluntary and simulated contractions of the quadriceps femoris muscle. Respir Physiol Neurobiol 2007;157:341-347.
203. Stevens JE, Mizner RL, Snyder-Mackler L. Neuromuscular electrical stimulation for quadriceps muscle strengthening after bilateral total knee arthroplasty: a case series. J Orthop Sports Phys Ther 2004;34:21-29.
204. Lai HS, De Demenico G, Strauss GR. The effect of different electro-motor stimulation training intensities on strength improvement. Aust J Physiother 1988;34:151-164.
205. Bax L, Staes F, Verhagen A. Does neuromuscular electrical stimulation strengthen the quadriceps femoris? A systematic review of randomized controlled trials. Sports Med 2005;35:191-212.
206. Milner-Brown HS, Miller RG. Muscle strengthening through electric stimulation combined with low-resistance weights in patients with neuromuscular disorders. Arch Phys Med Rehabil 1988;69:20-24.
207. Skura Cl, Fowler EG, Wetzel GT, Graves M, Spencer MJ. Albuterol increases lean body mass in ambulatory boys with Duchenne or Becker muscular dystrophy. Neurology 2008;70:137-143.
208. Dorchies OM, Wagner S, Vuadens O, Waldhauser K, Buetler TM, Kucera P, et al. Green tea extract and its major polyphenol epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy. Am J Physiol Cell Physiol 2006;290:C616-C625.
209. Call JA, Voelker KA, Wolff AV, McMillan RP, Evans NP, Hulver MW, et al. Endurance capacity in maturing mdx mice is markedly enhanced by combined voluntary wheel running and green tea extract. J Appl Physiol 2008;105:923-932.
210. Chan A, Reichmann H, Kogel A, Beck A, Gold R. Metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy. J Neurol 1998;245:681-685.
211. Chen RS, Huang CC, Chu NS. Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind crossover study. Eur Neurol 1997;37:212-218.
212. Spurney CF, Rocha CT, Henricson E, Florence J, Mayhew J, Gorni K, CINRG Investigators . CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy. Muscle Nerve 2011;44:174-178.
213. Skough K, Krossen C, Heiwe S, Theorell H, Borg K. Effects of resistance training in combination with coenzyme Q10 supplementation in patients with post-polio: a case study. J Rehabil Med 2008;40:773-775.
214. Tarnopolsky MA. Potential benefits of creatine monohydrate supplementation in the elderly. Curr Opin Clin Nutr Metab Care 2000;3:497-502.
215. Casey A, Greenhaff PL. Does dietary creatine supplementation play a role in skeletal muscle metabolism and performance? Am J Clin Nutr 2000;72:607S-617S.
216. Kley RA, Tarnopolosky MA, Vorgerd M. Creatine for treating muscle disorders. Cochrane Database Syst Rev 2011;2:CD004760.